Physician profile
Dukens Labaze
NPI 1891287140
$45,942.19
in general payments reported to CMS, 2019-2025
8 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.32 · 2023: $2,485 · 2024: $22K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $32K · Travel and Lodging: $9,243 · Food and Beverage: $4,866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $31,795.00 |
| Travel and Lodging | $9,242.88 |
| Food and Beverage | $4,865.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $32,200.13 | 2024-2025 | Journey II, Or3o Dual Mobility, Real Intelligence |
| Zimmer Biomet Holdings, INC. | $8,879.37 | 2023-2025 | Persona, Affixus, Avenir |
| Stryker Corporation | $3,094.72 | 2022-2025 | Mako, Triathlon, Pro |
| Encore Medical, LP | $1,309.70 | 2024 | Djo Surgical |
| Globus Medical, INC. | $162.66 | 2025 | Autobahn |
| Depuy Synthes Sales INC. | $146.54 | 2024 | Na, Va-Lcp |
| Ortho Development Corporation | $109.33 | 2025 | |
| Heraeus Medical, LLC. | $39.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dukens Labaze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.